查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546151

全球呼吸診斷市場

Respiratory Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球呼吸診斷市場預計將達到 98 億美元

全球呼吸診斷市場預計到2023年將達到72億美元，預計2023年至2030年複合年成長率為4.5%，到2030年將達到98億美元。機械檢測是本報告分析的細分市場之一，預計複合年成長率為 4.6%，到分析期結束時將達到 58 億美元。分析期間，影像檢查領域的複合年成長率預計為 5.1%。

美國市場預計20億美元，中國預計複合年成長率7.5%

預計 2023 年美國呼吸診斷市場規模將達 20 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達21億美元，2023-2030年分析期間複合年成長率為7.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.3% 和 3.7%。在歐洲，德國的複合年成長率預計為 2.9%。

全球呼吸診斷市場 - 主要趨勢和促進因素總結

呼吸診斷：推進肺部疾病的檢測

呼吸診斷透過提供更準確、非侵入性和快速的檢測方法，正在徹底改變肺部疾病的檢測和管理。這些診斷方法包括各種測試，包括肺活量測定、血液氣體分析和影像技術，以評估肺功能並診斷結核病、氣喘、慢性阻塞性肺病（COPD）和肺部感染疾病。許多呼吸系統疾病如果不及時治療可能會導致嚴重的併發症，因此早期發現對於有效的治療和管理至關重要。診斷技術的進步使醫療保健提供者能夠更準確地診斷呼吸系統疾病，從而改善患者的治療結果並提高受影響者的生活品質。

哪些技術進步正在改善呼吸診斷？

科技的進步大大提高了呼吸診斷的能力，使其更加準確、更容易獲得、更易於使用。高解析度電腦斷層掃描 (HRCT) 和磁振造影(MRI) 等影像技術的創新使肺部結構的詳細可視化成為可能，從而可以及早發現標準 X光無法看到的疾病。此外，手持式肺計量計和脈動式血氧監測儀系統等可攜式照護現場點診斷設備的發展使醫療保健提供者更容易在各種環境中進行測試，包括基層醫療辦公室和患者家用。分子診斷的進步，包括聚合酵素鏈鎖反應（PCR）和次世代定序（NGS），也提高了檢測與呼吸道疾病相關的特定病原體和遺傳標記的能力。這些創新正在推動呼吸診斷的採用，從而可以更全面、更準確地評估肺部健康狀況。

呼吸診斷的主要用途和好處是什麼？

呼吸診斷廣泛應用於臨床環境，包括評估肺功能、診斷呼吸系統疾病和監測治療效果。在基層醫療中，肺量計是一種常見的診斷工具，可測量肺活量和氣流，有助於診斷氣喘和慢性阻塞性肺病等疾病。在醫院，血液氣體分析和 HRCT 掃描等更先進的測試用於評估呼吸道疾病的嚴重程度並決定治療計劃。分子診斷在呼吸系統檢測中的應用變得越來越重要，特別是在識別引起呼吸道感染疾病的特定病原體並實現針對性治療方面。呼吸診斷的主要好處包括早期發現肺部疾病、提高診斷準確性以及改善對疾病進展和治療結果的監測。這些好處使呼吸診斷成為現代醫療保健的重要組成部分，支持更好的患者照護和疾病管理。

推動呼吸診斷市場成長的因素有哪些？

呼吸診斷市場的成長受到多種因素的推動。氣喘、慢性阻塞性肺病和肺部感染疾病等呼吸系統疾病的盛行率不斷上升是一個重要的促進因素，這些疾病對準確、可靠的診斷工具的需求不斷成長。技術進步，特別是診斷影像、分子診斷和照護現場設備方面的進步，也透過提高呼吸診斷的能力和可及性來推動市場成長。人們越來越認知到早期發現和管理呼吸系統疾病的重要性，這進一步推動了對這些診斷的需求，因為早期療育可以預防併發症並改善患者的治療結果。此外，COVID-19 大流行的持續影響凸顯了對有效呼吸系統診斷的需求，推動了該領域的進一步投資和創新。這些因素加上醫療技術的不斷進步，正在推動呼吸診斷市場的持續成長。

受訪企業範例（43家知名企業）

  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cosmed Srl
  • Philips Healthcare
  • SDI Diagnostics
  • Seegene, Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP14425

Global Respiratory Diagnostics Market to Reach US$9.8 Billion by 2030

The global market for Respiratory Diagnostics estimated at US$7.2 Billion in the year 2023, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Mechanical Tests, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Imaging Tests segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 7.5% CAGR

The Respiratory Diagnostics market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Respiratory Diagnostics Market - Key Trends and Drivers Summarized

Respiratory Diagnostics: Advancing the Detection of Lung Diseases

Respiratory diagnostics are revolutionizing the detection and management of lung diseases by providing more accurate, non-invasive, and rapid testing methods. These diagnostics encompass a range of tests, including spirometry, blood gas analysis, and imaging techniques, that assess lung function and detect conditions such as tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and lung infections. Early detection of respiratory diseases is crucial for effective treatment and management, as many of these conditions can lead to severe complications if left untreated. With advancements in diagnostic technology, healthcare providers can now diagnose respiratory conditions with greater precision, leading to improved patient outcomes and a higher quality of life for those affected.

What Technological Advancements Are Enhancing Respiratory Diagnostics?

Technological advancements are significantly enhancing the capabilities of respiratory diagnostics, making them more accurate, accessible, and user-friendly. Innovations in imaging technology, such as high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI), allow for detailed visualization of lung structures, enabling the early detection of diseases that may not be apparent on standard X-rays. Additionally, the development of portable and point-of-care diagnostic devices, such as handheld spirometers and pulse oximeters, has made it easier for healthcare providers to conduct tests in various settings, including primary care offices and patient homes. Advances in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), have also improved the ability to detect specific pathogens and genetic markers associated with respiratory diseases. These technological innovations are driving the adoption of respiratory diagnostics, providing more comprehensive and accurate assessments of lung health.

What Are the Key Applications and Benefits of Respiratory Diagnostics?

Respiratory diagnostics are used in a wide range of clinical settings to assess lung function, diagnose respiratory diseases, and monitor treatment effectiveness. In primary care, spirometry is a common diagnostic tool used to measure lung capacity and airflow, helping to diagnose conditions like asthma and COPD. In hospitals, more advanced tests such as blood gas analysis and HRCT scans are used to assess the severity of respiratory conditions and guide treatment decisions. The use of molecular diagnostics in respiratory testing has become increasingly important, particularly in identifying the specific pathogens causing respiratory infections, enabling targeted treatment. The primary benefits of respiratory diagnostics include early detection of lung diseases, improved accuracy in diagnosis, and better monitoring of disease progression and treatment outcomes. These advantages make respiratory diagnostics a critical component of modern healthcare, supporting better patient care and disease management.

What Factors Are Driving the Growth in the Respiratory Diagnostics Market?

The growth in the Respiratory Diagnostics market is driven by several factors. The increasing prevalence of respiratory diseases, such as asthma, COPD, and lung infections, is a significant driver, as these conditions create a growing demand for accurate and reliable diagnostic tools. Technological advancements, particularly in imaging, molecular diagnostics, and point-of-care devices, are also propelling market growth by enhancing the capabilities and accessibility of respiratory diagnostics. The rising awareness of the importance of early detection and management of respiratory conditions is further boosting demand for these diagnostics, as early intervention can prevent complications and improve patient outcomes. Additionally, the ongoing impact of the COVID-19 pandemic has highlighted the critical need for effective respiratory diagnostics, driving further investment and innovation in this field. These factors, combined with the continuous advancement of medical technology, are driving the sustained growth of the Respiratory Diagnostics market.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cosmed Srl
  • Philips Healthcare
  • SDI Diagnostics
  • Seegene, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Respiratory Diagnostics: Overview & Outlook
    • Respiratory Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Mounting Burden of Respiratory Diseases: Major Driver
    • Pulmonary Function Test: Major Category
    • Imaging Tests Gain Traction
    • CT Screening for Improved Pulmonary Pathology
    • Bronchoscopy & Laryngoscopy for Evaluating the Airway Directly
    • Rising Cost of Medical Treatment Deters Growth
    • Rising Prevalence of Respiratory Diseases Propels Market Growth
    • Increasing Use of Diagnostic Tests in Early Detection and Disease Management Expands Addressable Market Opportunity
    • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Market Position
    • Growing Focus on Personalized Medicine and Targeted Therapies Drives Adoption of Respiratory Diagnostics
    • Surge in Demand for Point-of-Care and Rapid Testing Solutions Generates New Opportunities
    • Development of Non-Invasive and Minimally Invasive Diagnostic Tools Sustains Market Growth
    • Expanding Applications in Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throws Spotlight on Market Potential
    • Rising Adoption of Respiratory Diagnostics in Homecare Settings Propels Market Expansion
    • Surge in Demand for Diagnostic Solutions Amidst Global Respiratory Disease Outbreaks Expands Market Horizons
    • Growing Awareness of the Importance of Early Diagnosis in Improving Patient Outcomes Drives Market Adoption
    • Innovations in Artificial Intelligence and Machine Learning for Diagnostic Accuracy Generate New Market Opportunities
    • Rising Demand for Respiratory Diagnostics in Emerging Healthcare Markets Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Tuberculosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Chronic Obstructive Pulmonary Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Instruments & Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Services & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Mechanical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Imaging Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Molecular Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 34: World Respiratory Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • JAPAN
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • CHINA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • EUROPE
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • GERMANY
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • INDIA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • AFRICA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030

IV. COMPETITION